SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-006319
Filing Date
2018-05-15
Accepted
2018-05-15 16:02:09
Documents
68
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0318_yewbiopharm.htm 10-Q 510435
2 CERTIFICATION f10q0318ex31-1_yewbio.htm EX-31.1 9652
3 CERTIFICATION f10q0318ex31-2_yewbio.htm EX-31.2 9822
4 CERTIFICATION f10q0318ex32_yewbio.htm EX-32 4633
  Complete submission text file 0001213900-18-006319.txt   4041287

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE yewb-20180331.xml EX-101.INS 715043
6 XBRL SCHEMA FILE yewb-20180331.xsd EX-101.SCH 63479
7 XBRL CALCULATION FILE yewb-20180331_cal.xml EX-101.CAL 52845
8 XBRL DEFINITION FILE yewb-20180331_def.xml EX-101.DEF 156546
9 XBRL LABEL FILE yewb-20180331_lab.xml EX-101.LAB 494548
10 XBRL PRESENTATION FILE yewb-20180331_pre.xml EX-101.PRE 311592
Mailing Address 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Business Address 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731 626-401-9588
Yew Bio-Pharm Group, Inc. (Filer) CIK: 0001548240 (see all company filings)

IRS No.: 261579105 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54701 | Film No.: 18836208
SIC: 0100 Agricultural Production-Crops